These success, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two help the idea of targeting ACKR3 as a unique way to modulate the opioid process, which could open new therapeutic avenues for opioid-associated disorders. Morphine as well as other opioids https://earles031yvq1.blog-a-story.com/profile